Open AccessJournal Article
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. authors reply
About:
This article is published in The New England Journal of Medicine.The article was published on 1993-01-01 and is currently open access. It has received 78 citations till now. The article focuses on the topics: Stroke & Atrial fibrillation.read more
Citations
More filters
Journal ArticleDOI
Evidence based medicine: an approach to clinical problem-solving
William Rosenberg,Anna Donald +1 more
TL;DR: Evidence based medicine can be taught to, and practised by, clinicians at all levels of seniority and can be used to close the gulf between good clinical research and clinical practice.
Journal ArticleDOI
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
TL;DR: In this elderly, population-based sample, left atrial enlargement, increased left ventricular wall thickness, and reducedleft ventricular fractional shortening were predictive of risk for nonrheumatic atrial fibrillation.
Journal ArticleDOI
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Daniel E. Singer,Gregory W. Albers,James E. Dalen,Margaret C. Fang,Alan S. Go,Jonathan L. Halperin,Gregory Y.H. Lip,Warren J. Manning +7 more
TL;DR: This chapter about antithrombotic therapy in atrial fibrillation (AF) is part of the American College of Chest Physicians Evidence-Based Guidelines Clinical Practice Guidelines (8th Edition).
Journal ArticleDOI
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
Carl van Walraven,Robert G. Hart,Daniel E. Singer,Andreas Laupacis,Stuart J. Connolly,Palle Petersen,Peter J. Koudstaal,Yuchiao Chang,Beppie S. P. Hellemons +8 more
TL;DR: In this paper, the authors compared the risk of vascular and bleeding events in patients with nonvalvular atrial fibrillation treated with vitamin K inhibitors or acetylsalicylic acid (aspirin).
Journal ArticleDOI
Aspirin as a Therapeutic Agent in Cardiovascular Disease A Statement for Healthcare Professionals From the American Heart Association
TL;DR: Aspirin therapy confers conclusive net benefits in the acute phase of evolving myocardial infarction (MI) and should be administered routinely to virtually all patients with evolving acute MI, with perhaps the best benefit-to-risk ratio of any proven therapy for acute MI.
References
More filters
Journal ArticleDOI
Evidence based medicine: an approach to clinical problem-solving
William Rosenberg,Anna Donald +1 more
TL;DR: Evidence based medicine can be taught to, and practised by, clinicians at all levels of seniority and can be used to close the gulf between good clinical research and clinical practice.
Journal ArticleDOI
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
TL;DR: In this elderly, population-based sample, left atrial enlargement, increased left ventricular wall thickness, and reducedleft ventricular fractional shortening were predictive of risk for nonrheumatic atrial fibrillation.
Journal ArticleDOI
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Daniel E. Singer,Gregory W. Albers,James E. Dalen,Margaret C. Fang,Alan S. Go,Jonathan L. Halperin,Gregory Y.H. Lip,Warren J. Manning +7 more
TL;DR: This chapter about antithrombotic therapy in atrial fibrillation (AF) is part of the American College of Chest Physicians Evidence-Based Guidelines Clinical Practice Guidelines (8th Edition).
Journal ArticleDOI
Aspirin as a Therapeutic Agent in Cardiovascular Disease A Statement for Healthcare Professionals From the American Heart Association
TL;DR: Aspirin therapy confers conclusive net benefits in the acute phase of evolving myocardial infarction (MI) and should be administered routinely to virtually all patients with evolving acute MI, with perhaps the best benefit-to-risk ratio of any proven therapy for acute MI.
Journal ArticleDOI
Recent National Patterns of Warfarin Use in Atrial Fibrillation
TL;DR: Warfarin use in atrial fibrillation has not increased recently, indicating inadequate implementation of this highly effective therapy and barriers to anticoagulation in real-world clinical practice need to be identified and addressed.